Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-019159
Filing Date
2025-02-12
Accepted
2025-02-12 19:19:43
Documents
2
Period of Report
2025-02-12

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2962
2 EX-24 ck0001774857-ex24.htm EX-24 12172
  Complete submission text file 0000950170-25-019159.txt   16621
Mailing Address C/O RETROPHIN, INC. 12255 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address
Baynes Roy D. (Reporting) CIK: 0001680739 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42513 | Film No.: 25616648

Mailing Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122 (858) 225-7696
Aardvark Therapeutics, Inc. (Issuer) CIK: 0001774857 (see all company filings)

EIN.: 821606367 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)